MONOVER

This brand name is authorized in France, Ireland, Japan, Poland

Active ingredients

The drug MONOVER contains one active pharmaceutical ingredient (API):

1 Ferric derisomaltose
UNII AHU547PI9H - FERRIC DERISOMALTOSE

Ferric derisomaltose is a complex of iron (III) hydroxide and derisomaltose, an iron carbohydrate oligosaccharide that releases iron. Iron binds to transferrin for transport to erythroid precursor cells to be incorporated into hemoglobin. It is used for the treatment of iron deficiency anemia (IDA) in adult patients.

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
MONOVER Solution for injection / infusion Health Products Regulatory Authority (IE) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
B03AC Iron trivalent, parenteral preparations B Blood and blood forming organs → B03 Antianemic preparations → B03A Iron preparations
Discover more medicines within B03AC

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: FR Base de données publique des médicaments Identifier(s): 60717355
Country: JP 医薬品医療機器総合機構 Identifier(s): 3222405A1026, 3222405A2022
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100225428

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.